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This study reports the localisation of the [“P]IP, binding site on highly purifted membrane fractions prepared usin high-voltage free-flow 
electrophorcsis. Binding studies on mixed membranes, carried out at 4OC, revealed a binding site with a Kd = 86 nfrl and/?,, = 5.3 pmohma protein. 
The binding was potently inhibited by hcparin. High-voltage free-flow cleetrophoresis was used to further purify surface and intracellular 
membranes, The intracellular membranes showed a 5-fold enrichment of binding sites with rcspeet to the parent mixed membranes with the same 
Kd (80 nM), but the surface membranes showed an absence of binding activity. The results indicate the localisation of the IP, receptor on highiy 
purified intracellular membranes. 
Inositol trisphosphnte; Binding site loealisation; Human platelets 
1. INTRODUCTION 
The activation of platelets by agents uch as thrombin 
and thromboxane leads to the formation of inositol 
phosphates and the elevation of cytosolic Ca?’ levels. 
The role of inositol trisphosphate (IP,) in causing Ca2+ 
release from intracellular stores is well established [I], 
however the contribution played by IPs in Ca?’ influx 
is still controversial. Whether the effect on Ca’+ influx 
occurs as a direct interaction with the plasma membrane 
or indirectly via an interaction with the intracellular 
stores remains to be resolved. The localisation of bind- 
ing sites on highly purified membrane fractions may 
help resolve this controversy. Binding sites on particu- 
late fractions for radiolabelled IP3 have been charac- 
terized in many different tissues (e.g. [2-61) including 
platelets [7,83 with dissociation constants varying from 
0.1-70 nM depending upon the tissue, method of 
preparation of membranes and the conditions of the 
binding assay. Additionally, the IPs receptor has been 
purified from a number of tissues [9, IO] and cloned [133. 
The purified receptor when reconstituted into liposomes 
has also been shown to mediate Ca’+ flux [ 141 and single 
channel activity [ 151. 
membrane channels in T-lymphocytes [20] and also on 
Ca?’ fluxes on plasma membrane fractions prepared 
using Percoll density gradients from platelets [21]. Im- 
munohistochemical studies on Purkinje cells using anti- 
bodies have provided clearer evidence that the IPj re- 
ceptor is distributed on all regions of the ER and the 
nuclear envelope [22,23] but particularly on the smooth 
ER [24]. 
The purpose of this study was to determine the lo- 
calisation of the [3zP]IP, binding site using highly 
purified preparations of platelet surface and intracel- 
lular membranes prepared by high-voltage free-flow 
electrophoresis. Previous tudies have extensively char- 
acterized these membrane fractions with respect to 
protein and lipid constituents, marker enzymes [25,26], 
the ability of intracellular membranes to sequester Ca*’ 
[27,28] and to release itwith IP, [29]. This study reports 
on the localisation of the [“PJlP, binding site on these 
membrane systems. 
2. MATERIALS AND METHODS 
2,l. Matedah 
In all of the binding studies reported thus far the 
particulate preparations are impure and contain ele- 
ments from both plasma and intracellular membranes 
and thus a localization of the receptors for IP3 on the 
endoplasmic reticulum (ER) where its Ca?+ releasing 
action has been established, has not been exclusive. In- 
deed, a number of binding studies have revealed the site 
to be on AAAbAlAu.une s....- Y. a.n-~m +*=+lres that co-migrate with 
plasma membranes [16-181 and even in nuclei [IS]. IP3 
has also been suggested to have direct actions on plasma 
[rzP]Inositol trisphosphat: (IWO Wmmol) and unlahellcd inositol 
trisphosphate were obtained from Amersham International (UK). 
Neuraminidase (type X) was purchased from Sigma Chemic;ll Co., 
Dot-set, UK. All other reagents were of analytical grade. 
2.2, MerAods 
The proeedutr for the preparation of surface and intracellular 
membranes, i.c. separation of platelets from blood, neuraminidasc 
treatment, sonieation of platelets. eparation of mixed membranes on 
sorbitol density gradients and further fractionation into intracellular 
and surface membranes by high-voltage free-flow eleetrophoresis 
using a VAP 5 apparatus tias idmiieai io that dcseribed in 1291 :vhh 
the following modifications. During sonication of the platelets the 
protease inhibitor cocktail contained 0.3 U/ml aprotinin. Spg/ml pep 
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Fig. 1. Kinetics of [‘zP]IPI binding to platelet mixed mcmbrancs and its displacement. (a) Incubations containing 0.1 nM [“P]IP, are carried out 
as descclbed in section 2 and reactions topped by rapid filtration. (b) Unlabelled IPJ (1 PM) is added after 20 min incubation. Total cpm in the 
reactions reprcsetil 33802 cpm. Points arc means of duplicates with three other preparations showing similar results. 
statin A and 200 FM PMSF. AL the end. the membrane fractions were 
concemrated by centrifugation at 100,000 xp for 1 hand resuspended 
in 0.34 M sorbitol, IO mM HEPES pH 7.2 for analysis. 
Binding of [‘:P]IPj to the membrane fractions was carried out using 
a modification of the procedure by Worley et al. [3] and Tones et nl. 
[30]. kcaction mixtures in 0.5 ml contained 100 mM KCI, 20 mM 
NaCI, I mM EGTA, 25 mM Na?HPO,, I mg/ml BSA, pH 8.0,O.l nM 
[‘?P]IP,, 200 pg membrane protein (or 100 #g of intracellular 
membranes) and where stated varying concentrations of unlabelled 
IPI. Incubations were carried out at 4% for 30 min after which 450 
,uI aliquots were rapidly filtered through a 0.45,~ filter, which was then 
washed twice with 5 ml of a buffercontaining 0.25 M sorbitol, 1G mM 
K.HPO, pH 7.0. Th>: %dioactivity on the filter was counted by liquid 
s&tillatinn. ’ 
3. RESULTS AND DISCUSSION 
The binding of [3’P]IPJ was initially determined on 
mixed membranes prepared from platelets using sor- 
bitol density gradients. Fig. la shows the time course of 
the binding of 0.1 nM [‘“P]IPJ to platelet membranes at 
4OC. Binding is rapid over the first 10 min and reached 
equilibrium thereafter. Addition of 1 yM non-labelled 
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IP3 at equilibrium (after 20 min incubation) leads to a 
displacement of [32P]IP3 such that less than 10% is re- 
maining after 30 min incubation (Fig. 1 b). Inhibition of 
[3zP]IP3 binding also occurs to the same extent if un- 
labelled IPJ (1 yM) is added at the start of the incuba- 
tions. The displacement of [3’PJIP, by unlabelled IP, 
were further characterised using different concentra- 
tions of unlabelled IP3 (l-1000 nM) and Fig. 2a shows 
a typical displacement curve with concentrations of 500 
nM IP3 and above giving maximal displacement, Anal- 
ysis of the data using a Scatchard plot (Fig. 2b) gave a 
straight line by regression analysis with a Kd = 86 nM 
and a binding capacity tp,,tiX = 5.3 pmol/mg protein). 
The binding site was then further characterized cx- 
amining the effects of various agents added at the start 
of the incubations. Inositol 1,4-bisphosphate shows 
only very minimal displacement at high concentrations 
(up to 50 yM showing no effect and 100 ,uM giving 38% 
displacement). Heparin has been shown in many studies 
to antagonise the actions of IP, and to displace IPj from 
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Fig. 2. Displacemem (a) and Scatchard analysis (b) of [“‘P]IP, binding to platelet mixed membranes. Incubation conditions as in section 2. Points 
are means of duplicates and the data shown is typical of three memb:ane preparations, 
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Fig. 3. Binding and displacement of [“7P]1P1 binding to purilkd surface and intracellular membranes. (a) 100 pg of membrane fractions wcrc 
incubated with 0. I nM [llP]IP, and varying concentrations of unlabelled IP,. Total radioaclivity in reaclions represen:. 38037 cpm. IM, intracellular 
membranes; SM, surface membranes. (b) Scatchard analysis of the data for inlracellular membranes. Due to small amounts of puriEcd membranes 
obtained points arc single determinations with two other preparations showing similar results. 
its binding site. Using mixed membranes, unfrac- 
tionated heparin potently displaced [32P]1P3 from its 
binding site with an ECso = 2 ,@ml and total displace- 
ment shown at concentrations greater than 10 ~g/ml 
(results not shown). 
Studies were then carried out to localise the IP3 bind- 
ing, using membranes purified by free flow electropho- 
resis to yield surface and intracellular membranes. As 
indicated earlier these membrane fractions have been 
extensively characterized [25,26]. The surface 
membrane fractions are particularly rich in surface gly 
coproteins and do not sequester Ca” via an ATP-de- 
pendent mechanism and thus an effect of IPb on Ca” 
fluxes across the purified plasma membranes cannot be 
directly tested [27,28]. The intracellular membranes 
however have been shown to sequester Ca” and have 
the associated Ca?‘, Mg?* ATPase activity [27,28]. Fig. 
3a shows the binding of [32P]1P3 to the purified 
membrane fractions and its displacement by various 
levels of unlabelled 1P3. The intracellular membranes 
exhibited binding of [3’P]IP3 which was displaced by 
increasing concentrations of unlabelled IPj. Scatchard 
analysis revealed a & = 80 nM with an increased bind- 
ing capacity of 23 pmollmg protein (Fig. 3b). The 
surface membranes however showed little binding with 
some preparations howing no difference between spe- 
cific and non-specific binding. Fig. 4 shows analysis of 
data from 3 different membrane preparations compar- 
ing binding activities of the purified fractions with 
respect o the parent mixed membranes. There is a clear 
enhancement ofbinding activity (S-fold) in intracellular 
membranes with a marked absence of this activity in 
surface membranes. 
As indicated earlier, the role of IP, in releasing Ca” 
from intracellular stores is well established. This study 
shows that using highly purified platelet intracellular 
and surface membranes that the [32P]1Pj binding site is 
local&d exclusively on intracellular membranes in line 
with its ability to release Ca” from these stores. A 
number of studies have suggested the direct involve- 
ment of lPs in ion fluxes across the plasma membrane, 
e.g. in T-lymphocytes [20] and in plasma membranes 
prepared from platelets using Percoll density gradients 
where lPJ was reported to induce Ca” flux in mem- 
branes loaded with Ca” via a Na+/Ca” exchange mech- 
anism [21]. However in the latter study it is not clear 
whether this effect is due to a specific binding site on the 
membranes or a non-specific effect due to the abnormal 
dose-response relationship that was reported. The 
absence of a measurable binding site for IPJ in platelet 
plasma membranes prepared using free flow electropho- 
resis provides evidence against a direct role for IP3 in 
MM IM SM 
Fig. 4. Comparison of p*P]IP, binding to intracellular and surface 
membranes with respect to the parent mixed membranes. The data are 
calculated from the specific binding of 0. I nM [‘?P]lP, to membrane 
fractions and then expressed as fold enrichment with respect o the 
activity in the parent mixed membranes (which ranged between IO-16 
fmol iPs immihng pr0tsinj. XL4, mixed incmbrancs; IL% in:raa!- 
lular membranes; SM. surface membranes. The data represent means 
?r S.E.M. of three determinations on dilferent membnnc prepam- 
lions. 
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mediating Ca’* fluxes across the plasma membranes. 
The IP3 sensitive Ca?’ store has been suggested to be a 
specialised organelle which may either be a part of, or 
distinct from the endoplasmic reticulum [31,32], and it 
probably contains the Ca’+ binding protein calreticulin 
in the lumen [33-351. Whether the platelet intracellular 
membranes prepared by free flow electrophoresis con- 
tain calreticulin remains to be determined. 
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